Health Care
EUPRAXIA PHARMACEUTICALS INC EPRX
$9.15
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1392 by number of owners
% of all portfolios
0.00%
Rank #1051 by combined value
Net managers Q3 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.3%
of Beutel, Goodman & Company's portfolio
Live price
Compare with the quarter-end price of $9.15 reported in the 13F
Superinvestors holding EPRX
| Recent activity | |||
|---|---|---|---|
| Beutel, Goodman & Company · Beutel, Goodman & Company | 0.3% | Reduce-2.7% | $32.3M |